C
Colin G. Steward
Researcher at University of Bristol
Publications - 127
Citations - 7236
Colin G. Steward is an academic researcher from University of Bristol. The author has contributed to research in topics: Transplantation & Barth syndrome. The author has an hindex of 45, co-authored 127 publications receiving 6650 citations. Previous affiliations of Colin G. Steward include St. Michael's GAA, Sligo & Bristol Royal Hospital for Children.
Papers
More filters
Journal ArticleDOI
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers
Mark Cobbold,Naeem Khan,Batoul Pourgheysari,Sudhir Tauro,Dorothy McDonald,Husam Osman,Mario Assenmacher,Lucinda Billingham,Colin G. Steward,Charles Crawley,Eduardo Olavarria,John M. Goldman,Ronjon Chakraverty,Premini Mahendra,Charles Craddock,Charles Craddock,Paul Moss,Paul Moss +17 more
TL;DR: A novel approach to adoptive transfer of donor-derived CMV-specific CD8+ T cell clones has considerable potential for antigen-specific T cell therapy.
Journal ArticleDOI
Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)
Pia Ostergaard,Michael A. Simpson,Fiona Connell,Colin G. Steward,Glen Brice,Wesley J. Woollard,Dimitra Dafou,Tatjana Kilo,Sarah F. Smithson,Peter Lunt,Victoria Murday,Shirley Hodgson,Russell Keenan,Daniela T. Pilz,Ines Martinez-Corral,Taija Makinen,Peter S. Mortimer,Steve Jeffery,Richard C. Trembath,Sahar Mansour +19 more
TL;DR: It is indicated that haploinsufficiency of GATA2 underlies primary lymphedema and predisposes to acute myeloid leukemia in Emberger syndrome.
Journal ArticleDOI
Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines.
Charles Peters,Colin G. Steward +1 more
TL;DR: The primary goals of HCT for selected inherited metabolic diseases have been to promote long-term survival with donor-derived engraftment and to optimize the quality of life.
Journal ArticleDOI
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease
Claire Booth,Kimberly Gilmour,Paul Veys,Andrew R. Gennery,Mary Slatter,Helen Chapel,Paul T. Heath,Colin G. Steward,Owen P. Smith,Anna O'Meara,Hilary Kerrigan,Nizar Mahlaoui,Marina Cavazzana-Calvo,Alain Fischer,Despina Moshous,Stéphane Blanche,Jana Pachlopnik Schmid,Sylvain Latour,Geneviève de Saint-Basile,Michael H. Albert,Gundula Notheis,Nikolaus Rieber,Brigitte Strahm,Henrike Ritterbusch,Arjan C. Lankester,Nico G. Hartwig,Isabelle Meyts,Alessandro Plebani,Annarosa Soresina,Andrea Finocchi,Claudio Pignata,Emilia Cirillo,Sonia Bonanomi,Christina Peters,Krzysztof Kałwak,Srdjan Pasic,Petr Sedlacek,Janez Jazbec,Hirokazu Kanegane,Kim E. Nichols,I. Celine Hanson,Neena Kapoor,Elie Haddad,Morton J. Cowan,Sharon Choo,Joanne Smart,Peter D. Arkwright,Hubert B. Gaspar +47 more
TL;DR: A large cohort of 91 genetically defined XLP1 patients are described and characteristics and outcome data for 43 patients receiving hematopoietic stem cell transplant (HSCT) and 48 untransplanted patients are reported.
Journal ArticleDOI
Barth syndrome
Sarah Ln Clarke,Ann Bowron,Iris L. Gonzalez,Sarah J. Groves,Ruth Newbury-Ecob,Nicol Clayton,Robin P. Martin,Beverly Tsai-Goodman,Vanessa Garratt,Michael Ashworth,Valerie M. Bowen,Katherine R. McCurdy,Michaela K. Damin,Carolyn T. Spencer,Matthew J Toth,Richard I. Kelley,Colin G. Steward +16 more
TL;DR: The Barth syndrome (BTHS) is a rare X-linked genetic disease characterized by cardiomyopathy (CM), skeletal myopathy, growth delay, neutropenia and increased urinary excretion of 3-methylglutaconic acid (3-MGCA) as mentioned in this paper.